Cargando…
The Story of CD4(+)CD28(−) T Cells Revisited: Solved or Still Ongoing?
CD4(+)CD28(−) T cells are a unique type of proinflammatory T cells characterised by blockade of costimulatory CD28 receptor expression at the transcriptional level, which is still reversible by IL-12. In healthy individuals older than 65 years, these cells may accumulate to up to 50% of total CD4(+)...
Autores principales: | Maly, Kathrin, Schirmer, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365319/ https://www.ncbi.nlm.nih.gov/pubmed/25834833 http://dx.doi.org/10.1155/2015/348746 |
Ejemplares similares
-
Corrigendum to “The Story of CD4(+)CD28(−) T Cells Revisited: Solved or Still Ongoing?”
por: Maly, Kathrin, et al.
Publicado: (2015) -
Apoptotic Effects of Antilymphocyte Globulins on Human Pro-inflammatory CD4(+)CD28(−) T-cells
por: Duftner, Christina, et al.
Publicado: (2012) -
Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis
por: Schirmer, Michael, et al.
Publicado: (2002) -
Prevalence, clinical relevance and characterization of circulating cytotoxic CD4(+)CD28(- )T cells in ankylosing spondylitis
por: Duftner, Christina, et al.
Publicado: (2003) -
Enrichment of CD8+ CD28- cytotoxic T cells in circulating lymphocytes of patients with ankylosing spondylitis
por: Schirmer, M, et al.
Publicado: (2001)